Duesseldorf, November 20, 2015 - Today Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG, informed Dr. Axel Herberg, Chairman of the Supervisory Board of Gerresheimer AG, that after expiry of his contract in February 2018 he will not be available for an extension of his contract for personal reasons.
Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with 11,000 employees and manufacturing operations in the local markets, close to customers. It has over 40 production facilities in Europe, North and South America and Asia generating revenue in excess of EUR 1.3 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug-delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.